Filing Flows › Health Care › Envista Holdings (NVST)
Envista Holdings (NVST) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Envista Holdings (NVST) Q3 2026 earnings results →
Q3 2026 Revenue up 3% year over year to $692M · 74¢ of every $1 of revenue kept as net profit · operating margin 74.5%
Envista Holdings made $692M in Q3 2026 (+3% Y/Y): Specialty Products & Technologies $444M, Equipment & Consumables $248M. Operating margin 74.5%, net earnings $508M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $691.5M in Q3 2026, up 3% year over year and down 5% from the previous quarter. Specialty Products & Technologies was the largest line at 64% of revenue. Specialty Products & Technologies added $12.2M year over year (up 3%), 56% of the total change.
Gross margin was 57.9%, up 2.7 points from Q3 2025. Operating profit was $515.2M, a 74.5% margin (up 65.9 points year over year). Of the extra revenue versus Q3 2025, 2119% reached operating profit, above the 9% margin then. Net earnings were $508.3M. The effective tax rate was -1.6%.
Operating cash flow was $77.9M (down 1% year over year), 15% of net earnings. Non-cash charges added back $25.4M of depreciation and amortization and $9.8M of share-based compensation. Working capital and other items used $465.6M. Capital expenditures of $16.1M left free cash flow of $61.8M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $692M | +3% | 74.5% | $508M | $77.9M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $730M | +7% | 11.0% | $53.7M | $119M |
| Q1 2026 | 10-Q | May 6, 2026 | $706M | +14% | 8.9% | $38.7M | −$3.3M |
| Q4 2025 | 10-K | Feb 12, 2026 | $751M | +15% | 9.8% | $32.9M | $108M |
| Q3 2025 | 10-Q | Oct 30, 2025 | $670M | +12% | 8.6% | −$30.3M | $78.7M |
| Q2 2025 | 10-Q | Jul 31, 2025 | $682M | +8% | 6.8% | $26.4M | $88.7M |
| Q1 2025 | 10-Q | May 1, 2025 | $617M | -1% | 6.3% | $18.0M | $300K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
About Envista Holdings
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention, and loupes.
In its own words, from its 10-K, filed Feb 12, 2026.
Envista Holdings against its Dental Equipment & Supplies peers
The largest companies of the same SEC industry, each at its latest quarter.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| NVST Envista Holdings | Q3 2026 | $692M | +3% | 74.5% |
| XRAY Dentsply Sirona | Q3 2026 | $836M | -8% | 4.4% |
Source: Envista Holdings 10-Q on SEC EDGAR · CIK 1757073 · Dental Equipment & Supplies
Guidance and outlook
13F: who owns NVST and who is buying
More on NVST
- How Envista Holdings makes money: revenue by segment
- Envista Holdings next earnings date and what analysts expect
- Envista Holdings stock forecast, price target and fair value
- Who owns Envista Holdings stock: holders, funds and Congress trades
- Envista Holdings guidance and outlook
- Is Envista Holdings a takeover target? LBO and rumors
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Envista Holdings guidance history: guided vs reported
- Envista Holdings gross margin by quarter
- Envista Holdings operating margin by quarter
- Envista Holdings net income by quarter
- Envista Holdings free cash flow by quarter
- Envista Holdings R&D spending by quarter
- Envista Holdings capital expenditures by quarter
- Envista Holdings Specialty Products & Technologies revenue by quarter
- Envista Holdings Equipment & Consumables revenue by quarter